Bausch Health Companies Inc.: all 534 studies

Page 4 of 6. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)CompletedNCT00269399Phase 3Results posted
• A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial ParticipantsCompletedNCT07717918Phase 1
• A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive KeratectomyCompletedNCT07412496Phase 2
• A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin ResurfacingActive, not recruitingNCT07214272Not applicable
• Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne VulgarisCompletedNCT07205107
• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT07168902Phase 2
• A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye DiseaseCompletedNCT07128628Phase 2
• A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye DiseaseWithdrawnNCT07111013Phase 3
• A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens WearCompletedNCT07054606Phase 4
• A Study to Assess Safety, Tolerability, and Pharmacokinetics of Ascending Concentrations of Topical Ocular BL1332 in Healthy VolunteersActive, not recruitingNCT06978244Phase 1
• A Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular RednessCompletedNCT06803654Phase 3
• Revive Toric RWE StudyWithdrawnNCT06785194
• A Post-Market Clinical Follow-Up on Safety and Performance of the Ophthalmic Viscoelastic Devices Eyefill SC and Eyefill MBCompletedNCT06767917Not applicable
• A Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06594185Not applicable
• A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.Active, not recruitingNCT06565650Phase 4
• A Study to Evaluate the enVista® Aspire (EA) Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333028
• Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract ExtractionCompletedNCT06333015Not applicable
• Safety and Feasibility of the ELIOS System in POAG PatientsCompletedNCT05999006Not applicable
• Post-approval Follow-up Study of the IC-8 Apthera Intraocular Lens (IOL)CompletedNCT05758883
• Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ETCompletedNCT05739656
• Clinical Investigation of a Small Aperture Extended Depth of Focus Intraocular Lens in Patients With Complex CorneasCompletedNCT05574270Not applicable
• Evaluation of Visual Outcomes in Patients With Complex Corneas Implanted With the IC-8 IOLCompletedNCT05377515
• Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisActive, not recruitingNCT05297448Phase 3
• Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without AstigmatismCompletedNCT05264623Not applicable
• Safety, Tolerability, and Pharmacokinetics of Inhaled Virazole Administered Via Air-Jet Nebulizer in Healthy VolunteersCompletedNCT05229510Phase 1
• Canadian Real World Evidence Study of Brodalumab in Plaque Psoriasis to Understand the Impact on Quality of Life and Work ProductivityActive, not recruitingNCT05132231
• Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in CirrhosisActive, not recruitingNCT05071716Phase 3
• Excimer Laser Trabeculostomy Glaucoma Treatment StudyCompletedNCT04899063Not applicable
• Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative ColitisCompletedNCT04857112Phase 2
• Safety and Efficacy of a New Transepithelial Photorefractive Keratectomy TreatmentCompletedNCT04698174Not applicable
• Safety and Efficacy of Different Add Powers With a New Presbyopic Lasik Treatment AlgorithmCompletedNCT04617080Not applicable
• A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 TreatmentCompletedNCT04563026Phase 2
• Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19CompletedNCT04551768Phase 1
• Randomised, Placebo-controlled Safety and Pharmacokinetics Study of Novel Rifaximin Formulations in Healthy VolunteersCompletedNCT04529811Phase 1
• Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19_#2WithdrawnNCT04356677Phase 1
• A Study to Assess the Efficacy and Safety of Salix Probiotic Blend in Participants With Functional Gastrointestinal DisturbancesCompletedNCT04155801Not applicable
• An Extension Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic CancerWithdrawnNCT04151719Phase 3
• A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent RegimenCompletedNCT04149587
• A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular HypertensionWithdrawnNCT04140279Phase 4
• A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic CancerWithdrawnNCT04083651Phase 2/3
• A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque PsoriasisCompletedNCT03988439Phase 4
• A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque PsoriasisActive, not recruitingNCT03987763Phase 4
• Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control GelCompletedNCT03653403Phase 1
• A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®CompletedNCT03551873
• Qualitative Validation of Patient-Reported Outcomes (PRO) InstrumentCompletedNCT03536715
• Randomized,Study of APRISO 375 mg Versus the Approved APRISO 375 mg Capsules in Healthy Male and Female SubjectsCompletedNCT03327558Phase 1
• IOL Implantation After KAMRA Inlay RemovalCompletedNCT03320473Not applicable
• Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular LensCompletedNCT03314766
• Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)CompletedNCT03282929Phase 1
• An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric SubjectsActive, not recruitingNCT03240809Phase 4
• Corneal Endothelial Cell Density in Eyes Treated With a Fluocinolone Acetonide Intravitreal ImplantCompletedNCT03145025
• Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular InstallationsCompletedNCT03098953Phase 1
• Evaluation of the Safety, Systemic Pharmacokinetics, and TolerabilityCompletedNCT03063489Phase 1
• Topically Applied IDP-118 Lotion and HP Monad Lotion in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT03058744Phase 1
• Efficacy and Safety of IDP-120 Gel in the Treatment of Acne VulgarisCompletedNCT03003247Phase 2
• Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 GelCompletedNCT02850003Phase 1
• Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac CreamCompletedNCT02849873Phase 1
• Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne VulgarisCompletedNCT02849860Phase 1
• A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne VulgarisStatus unknownNCT02537483Phase 2
• A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne VulgarisStatus unknownNCT02535871Phase 3
• Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne VulgarisStatus unknownNCT02525822Phase 2
• Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic RadiculopathyCompletedNCT02508805Phase 3
• A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne VulgarisStatus unknownNCT02491060Phase 3
• Post Approval Study to Evaluate the Trulign™ Toric Posterior Chamber IOLCompletedNCT02394379
• Prospective Evaluation of the Long-term Effectiveness of the Femtosecond Laser-assisted Arcuate IncisionsStatus unknownNCT02164994
• A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and PresbyopiaStatus unknownNCT02112968Phase 4
• A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser Using LASIKStatus unknownNCT02071576Phase 4
• Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.CompletedNCT02039765Phase 1
• Long-term (3 Months) Safety of Femtosecond-laser Assisted Cataract SurgeryCompletedNCT02023437Phase 4
• Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)CompletedNCT01983306Phase 2
• A Prospective Safety and Effectiveness Study of the 500 Hz Technolas Perfect Vision Excimer Laser in Asian Eyes Using LASIKStatus unknownNCT01977807Phase 4
• Addressing of Efficacy and Safety of Femtosecond-laser Assisted Versus Manual Lens Fragmentation ProcedureCompletedNCT01971177Phase 4
• Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver CirrhosisCompletedNCT01904409Phase 2
• Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male VolunteersCompletedNCT01895985Phase 1
• Prospective Evaluation of the Effectiveness of the Femtosecond Laser-assisted Refractive Astigmatic Keratotomy.CompletedNCT01885780Phase 4
• An Evaluation of PDI-320 in Comparison to Its Monads in Adults With RosaceaStatus unknownNCT01828177Phase 2
• An Evaluation of PDI-192 0.1% in Comparison to PDI-192 0.15% in the Treatment of Mild to Moderate Atopic DermatitisCompletedNCT01826461Phase 2
• A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry EyeWithdrawnNCT01791426Not applicable
• A Single Centre Study to Analyze Cataract Surgery Following Femtosecond Laser-Assisted and Manual Cataract SurgeryCompletedNCT01769313Phase 4
• A Study to Address Precision and Refractive Predictability of Femtosecond Laser-assisted Astigmatic Keratotomy Following the Cataract SurgeryCompletedNCT01752218Not applicable
• Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 DaysCompletedNCT01736462Phase 1
• Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult SubjectsCompletedNCT01705938Phase 1
• Safety and Efficacy Study in Subjects With Seborrheic DermatitisCompletedNCT01703793Phase 2
• Prospective Evaluation of Circularity and Diameter of Femtosecond Laser Versus Manual Anterior Capsulotomy in Singapore National Eye CentreCompletedNCT01693211Not applicable
• A Phase 2 Dose Ranging, Evaluator-Blinded Study to Evaluate the Safety of Topical IDP-118Status unknownNCT01670513Phase 1/2
• Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)CompletedNCT01647906
• Prospective Investigation of SUPRACOR Visual Outcomes of Presbyopic Hyperopic Patients With and Without AstigmatismStatus unknownNCT01628146Phase 4
• Safety and Efficacy Study to Treat Bacterial VaginosisCompletedNCT01621399Phase 3
• Evaluation of Clinical Outcomes Following Implantation of a Sub-2mm Hydrophilic MICS Intraocular LensCompletedNCT01615861Not applicable
• Efficacy and Safety of Perlane-L in the Correction of Midface Volume DeficitStatus unknownNCT01565915Not applicable
• Arestin - Use in Subjects With Peri-ImplantitisCompletedNCT01539564Phase 3
• Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)CompletedNCT01517334Phase 3
• A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%CompletedNCT01437982Phase 4
• Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic KeratosisStatus unknownNCT01413763Phase 4
• SUPRACOR for Myopia and Myopic AstigmatismStatus unknownNCT01404884Phase 3
• Topical Antifungal Treatment for Tinea PedisCompletedNCT01396811Phase 3
• Topical Antifungal Treatment for Tinea PedisCompletedNCT01396785Phase 3
• Presbyopic Supracor Treatment for Near Myopic/Hyperopic Pseudophakic EyesCompletedNCT01387360Phase 4
• A Single Centre Study to Compare the Efficacy and Safety of Femtosecond Laser-Assisted Versus Manual Cataract SurgeryCompletedNCT01373853Phase 3
• Open-Label Treatment Extension of Protocol MNTX 302CompletedNCT01367613Phase 3

← Bausch Health Companies Inc. overview and focus areas